Mortality prediction of serum neutrophil gelatinase-associated lipocalin in patients requiring continuous renal replacement therapy
Yohan Park, Tae Hyun Ban, Hyung Duk Kim, Eun Jeong Ko, Jongmin Lee, Seok Chan Kim, Cheol Whee Park, Chul Woo Yang, Yong-Soo Kim, Byung Ha Chung
Korean J Intern Med. 2021;36(2):392-400.   Published online 2020 Jul 7     DOI: https://doi.org/10.3904/kjim.2019.446
Citations to this article as recorded by Crossref logo
Plasma neutrophil gelatinase-associated lipocalin independently predicts dialysis need and mortality in critical COVID-19
Jonas Engström, Hazem Koozi, Ingrid Didriksson, Anders Larsson, Hans Friberg, Attila Frigyesi, Martin Spångfors
Scientific Reports.2024;[Epub]     CrossRef
Reference interval for urinary neutrophil gelatinase-associated lipocalin in healthy adults in Jiangsu region in Eastern China: a multicenter study
Qian Liu, Xiaochun Chen, Huan Hang, Zhihui Xu, Fumeng Yang
Biomarkers in Medicine.2022; 16(1): 23.     CrossRef
Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
Chunhua Xu, Shan Lin, Longyi Mao, Zesong Li
Frontiers in Medicine.2022;[Epub]     CrossRef